Your browser is no longer supported. Please, upgrade your browser.
CRTX Cortexyme, Inc. weekly Stock Chart
CRTX [NASD]
Cortexyme, Inc.
Index- P/E- EPS (ttm)-1.99 Insider Own1.10% Shs Outstand29.44M Perf Week-13.33%
Market Cap1.38B Forward P/E- EPS next Y-2.67 Insider Trans-45.10% Shs Float16.02M Perf Month12.46%
Income-57.00M PEG- EPS next Q-0.62 Inst Own51.90% Short Float8.80% Perf Quarter-4.57%
Sales- P/S- EPS this Y-305.10% Inst Trans36.93% Short Ratio13.19 Perf Half Y4.78%
Book/sh6.98 P/B6.90 EPS next Y-3.40% ROA-32.20% Target Price78.14 Perf Year89.58%
Cash/sh5.05 P/C9.54 EPS next 5Y18.30% ROE-34.20% 52W Range20.14 - 73.84 Perf YTD-14.16%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-34.74% Beta-
Dividend %- Quick Ratio11.10 Sales past 5Y- Gross Margin- 52W Low139.28% ATR2.88
Employees23 Current Ratio11.10 Sales Q/Q- Oper. Margin- RSI (14)50.83 Volatility7.37% 5.74%
OptionableYes Debt/Eq0.00 EPS Q/Q-77.20% Profit Margin- Rel Volume0.75 Prev Close48.31
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume106.86K Price48.19
Recom2.10 SMA200.27% SMA506.98% SMA2002.66% Volume80,127 Change-0.25%
Jun-24-20Initiated H.C. Wainwright Buy $76
Jun-02-20Initiated Jefferies Buy $59
Jun-03-19Initiated JMP Securities Mkt Outperform $53
Jun-03-19Initiated Credit Suisse Underperform $14
Jun-03-19Initiated Canaccord Genuity Buy $42
Jun-03-19Initiated BofA/Merrill Neutral $28
Sep-24-20 08:00AM  
Sep-09-20 08:00AM  
Aug-27-20 08:00AM  
Aug-18-20 09:21AM  
Aug-17-20 08:00AM  
Aug-14-20 08:00AM  
Aug-12-20 08:11AM  
08:10AM  
Aug-06-20 04:05PM  
Jul-29-20 08:00AM  
Jul-28-20 06:09PM  
Jul-22-20 08:00AM  
Jun-14-20 07:00AM  
Jun-12-20 04:27PM  
Jun-09-20 08:00AM  
Jun-02-20 09:44AM  
May-27-20 08:00AM  
May-14-20 11:44AM  
May-12-20 04:05PM  
May-07-20 08:00AM  
May-06-20 08:30AM  
Apr-30-20 04:05PM  
Apr-06-20 08:30AM  
Apr-02-20 08:00AM  
Mar-17-20 08:00AM  
Mar-16-20 08:00AM  
Feb-13-20 08:00AM  
Feb-10-20 04:05PM  
Feb-05-20 09:00PM  
Jan-30-20 08:18AM  
Jan-13-20 08:00AM  
Jan-08-20 04:05PM  
Jan-05-20 08:14AM  
Jan-03-20 10:15AM  
Dec-22-19 06:38PM  
Dec-13-19 11:16AM  
Dec-11-19 06:32PM  
Dec-09-19 08:44AM  
Dec-07-19 01:00PM  
Dec-02-19 01:56PM  
Nov-26-19 04:05PM  
Nov-12-19 04:05PM  
Nov-08-19 10:34AM  
Nov-07-19 08:18AM  
Nov-01-19 08:00AM  
Oct-09-19 09:14AM  
Oct-07-19 09:36AM  
Sep-26-19 08:00AM  
Sep-23-19 10:54AM  
Aug-08-19 11:45AM  
Jul-31-19 04:05PM  
Jul-17-19 11:00AM  
Jul-10-19 08:00AM  
Jul-05-19 10:05AM  
Jul-01-19 02:08PM  
Jun-26-19 12:31PM  
Jun-19-19 08:00AM  
Jun-10-19 08:00AM  
May-08-19 07:22PM  
May-04-19 05:25PM  
Cortexyme, Inc., a clinical stage biopharmaceutical company, focuses on developing therapeutics for Alzheimer's disease and other degenerative disorders. Its lead drug candidate is COR388, an orally-administered brain-penetrating small molecule gingipain inhibitor, which is in Phase II/III for use in patients with mild to moderate Alzheimer's disease. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneJun 12Buy44.062,440107,5062,860,967Jun 15 06:55 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneJun 11Buy44.326,600292,5122,858,527Jun 15 06:55 PM
Lamond DavidDirectorJun 04Buy43.2749,1252,125,7951,747,109Jun 08 06:47 PM
PFIZER INC10% OwnerJun 03Sale40.18370,00014,866,6002,879,973Jun 04 04:25 PM
Detke Michael J.Chief Medical OfficerMay 27Option Exercise6.915,51538,10928,261May 29 04:48 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneMay 22Buy55.902,085116,5522,851,927May 22 06:03 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneMay 21Buy55.8052029,0162,849,842May 22 06:03 PM
EPIQ Capital Group, LLCIA/Managing Member of 10% OwneMay 20Buy57.956,085352,6052,849,322May 22 06:03 PM
Lamond DavidDirectorMay 19Buy56.2439,2002,204,6831,697,984May 19 06:41 PM
Lamond DavidDirectorMay 15Buy48.935,448266,5691,658,784May 19 06:41 PM
Detke Michael J.Chief Medical OfficerApr 02Option Exercise6.915,51538,10922,746Apr 06 05:39 PM
Detke Michael J.Chief Medical OfficerFeb 07Option Exercise6.9117,231119,06617,231Feb 10 06:15 PM